ArticleTherapeutics and clinical risk management2007
Update on the treatment of disseminated fusariosis: Focus on voriconazole.
Article in Therapeutics and clinical risk management, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 58 citations in OpenAlex.
- Clinical Features and Outcomes of Invasive Fusariosis: A Case Series in a Single Center with Literature Review.Infection & chemotherapy · 2023Article
- Non-Mucormycetes Causes of Fungal Rhino Sinusitis With Periocular Swelling in COVID-19 With Delta Variant.Cureus · 2022Article
- Fungal burn wound infection caused byAnnals of medicine and surgery (2012) · 2021Article
- Antimicrobial guide to posterior segment infections.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2021Review
- Native valve endocarditis, fusarium and end-stage renal disease.BMJ case reports · 2018Article
- Endogenous Fusarium Endophthalmitis During Treatment for Acute Myeloid Leukemia, Successfully Treated with 25-Gauge Vitrectomy and Antifungal Medications.Mycopathologia · 2018Article
- Rare case of disseminated fusariosis in a young patient with graft vs. host disease following an allogeneic transplant.Experimental and therapeutic medicine · 2016Article
- In Vitro Antifungal Activities against Moulds Isolated from Dermatological Specimens.The Malaysian journal of medical sciences : MJMS · 2016Article
- Serum voriconazole level variability in patients with hematological malignancies receiving voriconazole therapy.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2014Article
- Fusariosis, a complex infection caused by a high diversity of fungal species refractory to treatment.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2013Review
- The efficacy of voriconazole in 24 ocular Fusarium infections.Infection · 2013Article
- Identification of Fusarium species in formalin-fixed and paraffin-embedded sections by in situ hybridization using peptide nucleic acid probes.Journal of clinical microbiology · 2011Article
- Fusarium infection in lung transplant patients: report of 6 cases and review of the literature.Medicine · 2011Review
- International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole.Antimicrobial agents and chemotherapy · 2010Article
- Article
- Review
- Update on therapeutic approaches for invasive fungal infections in adults.Therapeutic advances in infectious diseaseReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Invasive fungal infections are a major cause of morbidity and mortality in immunocompromised patients, such as subjects with hematological malignancies and patients who underwent to hematopoietic stem cell transplantation (HSCT) or solid organ transplantation (SOT). Fusarium spp. cause a broad spectrum of infections in humans. Immunologically competent hosts show mainly localized skin infections, whereas disseminated fusariosis occurs almost exclusively in immunocompromised patients. Fusarium spp. are resistant to many antifungal agents with equivocal in vitro and in vivo susceptibility to amphotericin B. Voriconazole (VRC) is a triazole shown to be safe, well tolerated, and in vitro efficacious against Fusarium spp. Although clinical experience is limited, many case reports have shown the efficacy of VRC in the treatment of fusariosis.
Indexed as
Identifiers
18516266PMC2387295W62006590What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.